Who has invested in Kestrel Therapeutics?

Pfizer Ventures, Santé Health Ventures are named among the investors backing Kestrel Therapeutics.

Kestrel Therapeutics Funding: $13M Raised, Series A (2025)

Kestrel Therapeutics funding overview

Kestrel Therapeutics is based in Cambridge. Kestrel Therapeutics has raised $13M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in July 2025. The round record for Kestrel Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Pfizer Ventures, Santé Health Ventures. 2 distinct backers are named across the disclosed rounds.

Kestrel Therapeutics at a glance

Total raised: $13M
Latest round: Series A
Latest round date: July 2025
Headquarters: Cambridge
Notable investors: Pfizer Ventures, Santé Health Ventures

Frequently asked about Kestrel Therapeutics funding

How much has Kestrel Therapeutics raised?: Kestrel Therapeutics has raised $13M in total disclosed funding across the rounds on record.
Who has invested in Kestrel Therapeutics?: Pfizer Ventures, Santé Health Ventures are named among the investors backing Kestrel Therapeutics.
What was the latest Kestrel Therapeutics funding round?: The most recent disclosed round is a Series A, announced in July 2025.
Where is Kestrel Therapeutics based?: Kestrel Therapeutics is based in Cambridge.
When did Kestrel Therapeutics last raise?: The last disclosed Kestrel Therapeutics round closed in July 2025 at Series A.

Round data for Kestrel Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Kestrel Therapeutics Funding: $13M Raised, Series A (2025)

Kestrel Therapeutics funding overview

Kestrel Therapeutics at a glance

Frequently asked about Kestrel Therapeutics funding

Companies related to Kestrel Therapeutics (36)

Browse related funding lists (6)